How Targeted Cancer Drugs Disrupt the Cell Cycle
PLOS: DNA Science
JUNE 22, 2023
Here’s an article from 2002. I had the privilege to meet one of the first people to receive Gleevec, which I wrote about for Bioethics Today in 2006. Survivin inhibits apoptosis and promotes mitosis, so in excess a tumor forms. The earliest mention of survivin I could find was in a journal written in Polish with no abstract.
Let's personalize your content